EP3421033
SAMSETNING AF ATANASAVÍRI OG KÓBÍSISTATI TIL MEÐFERÐAR Á HIV-VEIRU
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.10.2014EP published:
27.7.2022EP application number:
18179796.0
EP translation filed:
9.9.2022Grant published:
15.10.2022EPO information:
European Patent Register
Max expiry date:
5.10.2034Expiry date:
5.10.2026Next due date:
31.10.2026
Title in English:
HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTATLanguage of the patent:
English
Timeline
Today
6.10.2014EP application
27.7.2022EP Publication
9.9.2022Translation submitted
15.10.2022Registration published
5.10.2026Expires
Owner
Name:
Bristol-Myers Squibb Holdings Ireland Unlimited CompanyAddress:
Hinterbergstrasse 16, 6312 Steinhausen, CH
Inventor
Name:
KOO, Otilia May YueAddress:
New Brunswick, New Jersey 08903, US
Name:
NIKFAR, FaranakAddress:
New Brunswick, New Jersey 08903, US
Name:
TAO, JingAddress:
New Brunswick, New Jersey 08903, US
Name:
KOTTALA, Niranjan KumarAddress:
AP 530056 Visakhapatnam, IN
Name:
VARIA, Sailesh A.Address:
New Brunswick, New Jersey 08903, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201361887574 PDate:
7.10.2013Country:
US
Classification
Categories:
A61K 9/24, A61K 31/4418, A61K 31/5377, A61P 31/12, A61P 31/18, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 15.9.2022
Expires: 5.10.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 25.9.2023
Expires: 5.10.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 17.9.2024
Expires: 5.10.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 2.10.2025
Expires: 5.10.2026
Payer: Árnason Faktor ehf.